Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health - A Randomized, Double-Blind, Placebo-Controlled Study

NCT07760506 is registered in ClinicalTrials.gov with Applied Science & Performance Institute as lead sponsor.

NCT NCT07760506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07760506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health - A Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
Applied Science & Performance Institute
Phase
Not applicable
Overall status
Recruiting
Start date
September 18, 2026
Completion date
August 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coenzyme q10, healthy aging, inflammaging, metabolic health, quercetin